ArticleFrontiers in immunology2026

Janus kinase inhibitor therapy for the treatment of spondyloenchondrodysplasia with immune dysregulation due to novel

Huilin Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.